BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 10, 2001
View Archived Issues
Active Biotech updates development programs
Read More
Exisulind may delay disease progression in prostate cancer patients
Read More
Copaxone reduces the percentage of permanent "black holes" in MS
Read More
Raven Biotechnologies delivers first MAb to ImmunoGen in ovarian cancer research collaboration
Read More
Matrix to seek E.U. approval of IntraDose by Q4 2001
Read More
Myriad Genetics uncovers potential of MPI-176716 as broad-spectrum cancer treatment
Read More
VaxGen receives further funding from NIH for HIV vaccine development
Read More
PLG microsphere formulation of human beta-amyloid(1-42) induces significant serum antibody response
Read More
Lorus and Faulding establish Virulizin distribution agreement for Latin America
Read More
Licensing agreement announced for ramoplanin
Read More
Karo Bio updates KB-002611 clinical development
Read More
Platinum complexes simultaneously targeting DNA and thioredoxin reductase
Read More
Positive data presented for OC-1016, a novel bone- and tissue-regenerating agent
Read More
Daiichi presents chemistry and pharmacology for diaminobutane AMPA receptor antagonists
Read More
3-Dimensional Pharmaceuticals to receive milestone payment for thrombin inhibitor program
Read More
Gene therapy for B-cell malignancies heading for phase II testing
Read More
Avigen's Coagulin-B gene therapy for hemophilia B trial on clinical hold
Read More
Phase II trial of Argatroban plus gpIIb/IIIa antagonists initiated in patients undergoing PCI
Read More
Fully humanized antibody for diagnosis and therapy of cancer
Read More
Rotta presents new leukotriene antagonists related to tyrosine
Read More
New nitroacridine derivatives with excellent in vivo antitumor activity
Read More
Inhibitors of PDE5 for sexual dysfunction and other disorders in development in Korea
Read More
Merck continues to identify inhibitors of protein prenyltransferases
Read More
Beta3-adrenoceptor agonists and use in urinary incontinence, obesity and diabetes
Read More